BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4790053)

  • 1. [Serum and urine bile acid studies in patients with decompensated liver cirrhosis].
    Wildgrube HJ; Dittmann K; Erb W
    Verh Dtsch Ges Inn Med; 1973; 79():953-4. PubMed ID: 4790053
    [No Abstract]   [Full Text] [Related]  

  • 2. Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism.
    Vlahcevic ZR; Juttijudata P; Bell CC; Swell L
    Gastroenterology; 1972 Jun; 62(6):1174-81. PubMed ID: 5050315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between serum biliary acid and respiratory test with 14C aminopyrine in patients with hepatic cirrhosis].
    Lesinigo E; Colombo W; Rocca F; Bonzi G; Musazzi R
    Clin Ter; 1985 Nov; 115(4):273-7. PubMed ID: 4085183
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography.
    Okuda H; Obata H; Nakanishi T; Hisamitsu T; Matsubara K; Watanabe H
    Hepatogastroenterology; 1984 Aug; 31(4):168-71. PubMed ID: 6479837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bile-acids in liver cirrhosis: prognostic significance evidenced by a multivariate statistical model.
    Siciliano M; Milani A; Marra L; Rossi L
    Z Gastroenterol; 1987 Nov; 25(11):721-5. PubMed ID: 3433853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
    El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
    Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of total serum bile acids in the initial and later phases of cirrhosis].
    Brutti AM; Falchi R; Luzzi Galeazzi S; Bazzucchi M; Lorenzoni L; Grignani F
    Minerva Dietol Gastroenterol; 1983; 29(1):27-32. PubMed ID: 6843854
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bile acid metabolism in patients with chronic hepatitis and liver cirrhosis].
    Klemashev IS; Dorofeev AA
    Sov Med; 1984; (6):44-6. PubMed ID: 6463746
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases.
    Takikawa H; Beppu T; Seyama Y
    Gastroenterol Jpn; 1984 Apr; 19(2):104-9. PubMed ID: 6735068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical study of the bile in chronic hepatitis and liver cirrhosis].
    Ivanov AI; Radchenko VG
    Ter Arkh; 1977; 49(2):60-4. PubMed ID: 860232
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum bile acids in chronic liver disease. II: liver cirrhosis].
    Santese R; Vai C; Andreuzzi B; Gelosa F; Alberti A
    G Clin Med; 1983; 64(7-8):225-33. PubMed ID: 6642107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood biliary acids in hepatology. II. Liver cirrhosis].
    Rautureau M; Chevrel B; Caroli J
    Rev Med Chir Mal Foie; 1967; 42(4):172-84. PubMed ID: 5623697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic value of serum bile acids in chronic diseases of the liver].
    Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
    Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fasting and postprandial serum bile acids in chronic liver diseases].
    Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G
    Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
    Invernizzi P; Setchell KD; Crosignani A; Battezzati PM; Larghi A; O'Connell NC; Podda M
    Hepatology; 1999 Feb; 29(2):320-7. PubMed ID: 9918905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conjugated serum bile acids in chronic liver diseases and cholestasis].
    Frosch B; Wagener H
    Acta Hepatosplenol; 1971; 18(4):273-86. PubMed ID: 5110093
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of conjugated bile acids in the serum during liver diseases].
    Paumgartner G; Grabner G
    Acta Hepatosplenol; 1970; 17(5):344-53. PubMed ID: 5516233
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile acid metabolism in cirrhosis. VI. Sites of blockage in the bile acid pathways to primary bile acids.
    Patteson TE; Vlahcevic ZR; Schwartz CC; Gustafsson J; Danielsson H; Swell L
    Gastroenterology; 1980 Oct; 79(4):620-8. PubMed ID: 7409381
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathological changes in serum bile acids in acute and chronic hepatitis].
    Cimino T; Spezia C; Marietti G
    Arch Sci Med (Torino); 1980; 137(3):471-5. PubMed ID: 7235935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.